A novel WWTR1‐CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Genes, Chromosomes and Cancer

• Publication date

  2011-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/gcc.20886PMID 21584898PMCID PMC3264678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hippo pathway in biological control and cancer development

  2011influential reference
• Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin*

  2011influential reference
• EWSR1‐POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty‐six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene

  2010cited by this paper
• WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ

  2010influential reference
• A Migration Signature and Plasma Biomarker Panel for Pancreatic Adenocarcinoma

  2010cited by this paper
• Cytogenetic analysis of a primary bone angiosarcoma.

  2009cited by this paper
• TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition*

  2009cited by this paper
• TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation*

  2009influential reference
• Ephrin B1 Regulates Bone Marrow Stromal Cell Differentiation and Bone Formation by Influencing TAZ Transactivation via Complex Formation with NHERF1

  2009cited by this paper
• A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells.

  2008cited by this paper
• TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway

  2008cited by this paper
• Epithelioid Hemangioendothelioma of Soft Tissue: A Proposal for Risk Stratification Based on 49 Cases

  2008cited by this paper
• CAMTAs: Calmodulin‐binding transcription activators from plants to human

  2007cited by this paper
• A Potential Dimerization Region of dCAMTA Is Critical for Termination of Fly Visual Response*

  2007cited by this paper
• Reduced Expression of CAMTA1 Correlates with Adverse Outcome in Neuroblastoma Patients

  2006cited by this paper
• Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma.

  2006cited by this paper
• A translocation involving the placental growth factor gene is identified in an epithelioid hemangioendothelioma.

  2006cited by this paper
• Intracellular calcium, endothelial cells and angiogenesis.

  2006cited by this paper
• Transcriptional activity of Pax3 is co-activated by TAZ.

  2006cited by this paper
• Chromosome 1p and 11q deletions and outcome in neuroblastoma.

  2005cited by this paper
• TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell Differentiation

  2005influential reference
• Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.

  2005cited by this paper
• Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma

  2005cited by this paper
• Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation

  2004cited by this paper
• Cell cycle-dependent transcriptional regulation of calmodulin-binding transcription activator 1 in neuroblastoma cells.

  2004cited by this paper
• Vascular tumors of bone: A study of 17 cases other than ordinary hemangioma, with an evaluation of the relationship of hemangioendothelioma of bone to epithelioid hemangioma, epithelioid hemangioendothelioma, and high-grade angiosarcoma.

  2003cited by this paper
• Identification and characterization of FLJ10737 and CAMTA1 genes on the commonly deleted region of neuroblastoma at human chromosome 1p36.31-p36.23.

  2003cited by this paper
• salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines.

  2002cited by this paper
• A Novel Family of Calmodulin-binding Transcription Activators in Multicellular Organisms*

  2002influential reference
• Epithelioid Vascular Tumors of Bone: A Review and Proposal of a Classification Scheme

  2001influential reference
• Expression of Fli-1, a Nuclear Transcription Factor, Distinguishes Vascular Neoplasms From Potential Mimics

  2001cited by this paper
• Translocation t(1;3)(p36.3;q25) Is a Nonrandom Aberration in Epithelioid Hemangioendothelioma

  2001cited by this paper
• Atypical and Malignant Glomus Tumors: Analysis of 52 Cases, With a Proposal for the Reclassification of Glomus Tumors

  2001cited by this paper
• Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation.

  2001cited by this paper
• Malignant vascular lesions of bone: radiologic and pathologic features

  2000cited by this paper
• TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteins

  2000cited by this paper
• Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.

  2000cited by this paper
• Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival

  1999cited by this paper
• Angiolymphoid hyperplasia with eosinophilia.

  1998cited by this paper
• Complex translocation [7;22] identified in an epithelioid hemangioendothelioma.

  1996cited by this paper
• The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation.

  1995cited by this paper
• Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase.

  1995cited by this paper
• Observations concerning the pathogenesis of epithelioid hemangioma (angiolymphoid hyperplasia).

  1991cited by this paper
• Observations concerning the pathogenesis of epithelioid hemangioma (angiolymphoid hyperplasia).

  1991cited by this paper
• NO and CO transfer.

  1990cited by this paper
• Vascular disorder.

  1987influential reference
• Epithelioid Hemangioendothelioma of Bone: A Clinicopathologic, Ultrastructural, and Immunohistochemical Study

  1986cited by this paper
• Angiolymphoid hyperplasia with eosinophilia. A clinicopathologic study of 116 patients.

  1985cited by this paper
• Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma.

  1982cited by this paper
• The Worm Turns.

  year unknowncited by this paper

• Pulsed ultrasound-stimulated microbubbles alter the tumor blood supply to enhance the efficacy of high-intensity focused ultrasound ablation of vascular tumors

  2026cites this paper
• Clinical and pathological analysis of pulmonary epithelioid vascular endothelial tumor

  2026cites this paper
• Cardiac epithelioid hemangioendothelioma with WWTR1::ACTL6A fusion and atypical histology mimicking cardiac angiosarcoma.

  2026cites this paper
• Incidence, prevalence and treatment of patients with Epithelioid Haemangioendothelioma (EHE) in Canada: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) and Multi-pronged Canadian Research in Epithelioid Haemangioendothelioma (PRO_CARE EHE) study.

  2025cites this paper
• AMPK Signaling Regulates Epithelioid Hemangioendothelioma Cell Growth

  2025cites this paper
• Radiation Therapy for Maxillary Sinus Epithelioid Hemangioendothelioma: A Case Report and Literature Review

  2025cites this paper
• Targeting the Hippo pathway in cancer

  2025cites this paper
• EHE cell cultures: a platform for mechanistic and therapeutic investigation

  2025cites this paper
• What is New in Pediatric Hepatic Neoplasms.

  2025cites this paper
• EHE cell cultures are a platform for mechanistic and therapeutic investigation

  2025cites this paper
• Epithelioid Hemangioendothelioma at the Junction of the Internal Jugular and Subclavian Vein: A Case Report.

  2025cites this paper
• Primary cutaneous epithelioid hemangioendothelioma of the temporal region: a case report

  2025cites this paper
• Hepatic epithelioid hemangioendothelioma with TFE3 rearrangement: a case report and literature review

  2025cites this paper
• Iris mesenchymal tumour in an infant.

  2025cites this paper
• A rare case report of epithelioid hemangioendothelioma of the left buttock: Challenges in diagnosis and management

  2025cites this paper
• Regulatory Mechanisms and Functional Roles of Readthrough Transcripts in Tumorigenesis

  2025cites this paper
• A case of hepatic epithelioid hemangioendothelioma with features resembling those of acute-onset autoimmune hepatitis that was undiagnosed before liver transplantation

  2025cites this paper
• EccDNA atlas in male mice reveals features protecting genes against transcription-induced eccDNA formation

  2025cites this paper
• Epithelioid hemangioendothelioma: A rare mimicker of post-traumatic hematoma

  2025cites this paper
• Liver transplantation as a treatment for cancer: comprehensive review

  2025cites this paper
• Pediatric Bone Tumors.

  2025cites this paper
• Massive/Mass-forming Ductular Reaction Associated With Vascular Occlusion in Various Underlying Basic Liver Diseases.

  2025cites this paper
• Epithelioid hemangioendothelioma of the lung: a clinical case

  2025cites this paper
• Clinicopathologic and Molecular Analysis of Primary Angiosarcoma of Bone—A Single Institution Experience

  2025cites this paper
• Replacing molecular testing with next-generation immunohistochemistry: I can diagnose that soft tissue tumor with a single antibody!

  2025cites this paper
• Diagnostic dilemmas in pulmonary mesenchymal tumors.

  2025cites this paper
• Cutaneous Hemangioma With Epithelioid Features Harboring TPM3/4::ALK Fusions

  2025cites this paper
• Nab-Paclitaxel Based Chemotherapy in the Treatment of Advanced Epithelioid Hemangioendothelioma: A Single-Institution Experience

  2025cites this paper
• Total talectomy and reconstruction using unrestricted 3D printed prosthesis for pediatric talus hemangioendothelioma

  2025cites this paper
• Clinician's primer for soft tissue sarcomas: Nuances of histologic subtypes

  2025cites this paper
• Targeting developmental vulnerabilities in childhood sarcomas

  2025cites this paper
• Real‐World Data Analysis of Genomic Alterations Detected by a Dual DNA–RNA Comprehensive Genomic Profiling Test

  2025cites this paper
• First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis

  2025cites this paper
• TRANSLATING MOLECULAR MECHANISMS OF EPITHELIOID HEMANGIOENDOTHELIOMA TO IMPROVE PATIENT OUTCOME.

  2025cites this paper
• Epithelioid Hemangioendothelioma: Treatment Landscape and Innovations for an Ultra-Rare Sarcoma

  2025cites this paper
• Hepatic epithelioid hemangioendothelioma, a rare liver tumor: a case report and review of the literature

  2025cites this paper
• CAMTA1-immunonegative epithelioid hemangioendotheliomas of the liver: a clinicopathological and molecular analysis of seven cases

  2025cites this paper
• Mesenchymal Tumors of the Liver: An Update Review

  2025cites this paper
• The Hippo pathway: Organ size control and beyond.

  2024cites this paper
• The challenges of hepatic epithelioid hemangioendothelioma: the diagnosis and current treatments of a problematic tumor

  2024cites this paper
• SARCP, A Clinical Next Generation Sequencing Assay for the Detection of Gene Fusions in Sarcomas: A Description of the First 652 Cases.

  2024cites this paper
• Clinical, Histopathological, and Immunophenotypic Spectrum of Hepatic Epithelioid Hemangioendothelioma: Eight Years' Data of a Tertiary Care Center from North India.

  2024cites this paper
• Comprehensive evaluation of clinical outcomes in hepatic epithelioid hemangioendothelioma subsets: insights from SEER Database and departmental cohort analysis

  2024cites this paper
• Primary vascular tumors of bone: a comprehensive literature review on classification, diagnosis and treatment.

  2024cites this paper
• Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant

  2024cites this paper
• Molecular Alterations in Pediatric Solid Tumors.

  2024cites this paper
• Uncovering the WWTR1::NCOA2 Gene fusion in low‐grade myoepithelial‐rich neoplasm with HMGA2 expression: A case report

  2024cites this paper
• Pediatric epithelioid haemangioma with intra- and exra-articular involvement around the hip joint: A case report

  2024cites this paper
• Proposed diagnostic and prognostic markers of primary malignant hepatic vascular neoplasms

  2024cites this paper
• Epigenetic determinants of fusion-driven sarcomas: paradigms and challenges

  2024cites this paper
• YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer

  2024cites this paper
• Hepatic Epithelioid Hemangioendothelioma in a Dog

  2024cites this paper
• Congenital Vascular and Lymphatic Diseases.

  2024cites this paper
• GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression

  2024cites this paper
• Metastatic Epithelioid Hemangioendothelioma of the Bone: A Case Report and Literature Review

  2024cites this paper
• CDK9 inhibition by dinaciclib is a therapeutic vulnerability in epithelioid hemangioendothelioma.

  2024cites this paper
• The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatments

  2024cites this paper
• Epithelioid haemangioma after bone surgery: an event not previously described.

  2024cites this paper
• Vascular tumors of intermediate malignancy: An update.

  2024cites this paper
• Immunohistochemical detection of cancer genetic abnormalities.

  2024cites this paper
• Atypical epithelioid cells in pleural effusion as foreign second population: A diagnostic cytopathology dilemma

  2024cites this paper
• Primary Pleural Epithelioid Angiosarcoma with Lung and Bone Metastases: A Case Report

  2024cites this paper
• Epithelioid hemangioendothelioma-its history, clinical features, molecular biology and current therapy.

  2024cites this paper
• Progress in histology specific treatments in soft tissue sarcoma

  2024cites this paper
• Vascular Neoplasms With NFATC1/C2 Gene Alterations

  2024cites this paper
• Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges.

  2024cites this paper
• Mesenchymal tumours of the pleura: review and update

  2023cites this paper
• Cytopathologic features of epithelioid hemangioendothelioma including touch imprints for rapid on-site evaluation

  2023cites this paper
• A Case Report and Review of Literature: Epithelioid Hemangioendothelioma—An Uncommon Challenging Case

  2023cites this paper
• Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to COL1A1‐PDGFB fusion gene

  2023cites this paper
• How Molecular Discoveries Have Changed Liver Tumor Pathology: A Brief Review.

  2023cites this paper
• Emerging mesenchymal tumour types and biases in the era of ubiquitous sequencing

  2023influential citation
• Epithelioid hemangioendothelioma of the distal lower extremity and the role of radiotherapy: A report of two cases

  2023cites this paper
• The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment

  2023cites this paper
• Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years.

  2023cites this paper
• A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review

  2023cites this paper
• Incidence, demographics, and survival of malignant hemangioendothelioma in the United States

  2023cites this paper
• Fusion transcriptome profiling defines the monoclonal origin of multifocal epithelioid haemangioma of bone

  2023cites this paper
• Current Model Systems for Investigating Epithelioid Haemangioendothelioma

  2023cites this paper
• A cutaneous epithelioid vascular tumor harboring a TPM3::ALK fusion

  2023cites this paper
• New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE)

  2023cites this paper
• Loss of CDKN2A cooperates with WWTR1(TAZ)-CAMTA1 gene fusion to promote tumor progression in epithelioid hemangioendothelioma.

  2023cites this paper
• NOTCH3 missense mutations as predictor of long-term response to gemcitabine in a patient with epithelioid hemangioendothelioma

  2023cites this paper
• Exploring real-world practices and challenges of sarcoma diagnosis in Morocco: a survey-based study among 144 pathologists

  2023cites this paper
• Pulmonary epithelioid hemangioendothelioma: a case report and review of literature

  2023cites this paper
• Establishing an RNA fusions panel in soft tissue sarcoma with clinical validation

  2023cites this paper
• Epithelioid hemangioendothelioma of the retroperitoneal giant type treated with Toripalimab: A case report

  2023cites this paper
• Vasculature is getting Hip(po): Hippo signaling in vascular development and disease.

  2023cites this paper
• Hepatic epithelioid hemangioendothelioma—a single-institution experience with 51 cases

  2023cites this paper
• Glomangiosarcoma-like Anaplastic Transformation in Papillary Thyroid Carcinoma: A Novel Form of Heterologous Differentiation and a Systematic Review of Heterologous Element Prevalence

  2023cites this paper
• Sarcoma of the Lung and Mediastinum.

  2023cites this paper
• The Recent Advances in Molecular Diagnosis of Soft Tissue Tumors

  2023cites this paper
• Prognostic Factors in Epithelioid Hemangioendothelioma: Analysis of a Nationwide Molecularly/Immunohistochemically Confirmed Cohort of 57 Cases

  2023cites this paper
• A novel WWTR1::AFF2 fusion in an intra‐abdominal soft tissue sarcoma with associated endometriosis

  2022cites this paper
• Treatment modalities and long-term outcomes of hepatic hemangioendothelioma in the United States.

  2022cites this paper
• Case Report: 18F-FDG PET/CT Demonstrating Malignant Spread of a Pulmonary Epithelioid Hemangioendothelioma

  2022cites this paper
• Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complex

  2022cites this paper
• The TAZ-CAMTA1 Fusion Protein Promotes Tumorigenesis via Connective Tissue Growth Factor and Ras–MAPK Signaling in Epithelioid Hemangioendothelioma

  2022cites this paper
• Molecular Characterization of Multifocal Granular Cell Tumors

  2022cites this paper
• Updated information regarding management of hepatic epithelioid hemangioendothelioma.

  2022cites this paper